News Hub | News Direct

Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

ZOE Study Reveals Eating a Plant Rich Diet Reduces Risk of Developing COVID-19 and Going to the Hospital

ZOE

Researchers at health science company ZOE, Harvard Medical School, and King’s College London found that people who eat a high quality, gut-friendly diet* are less likely to develop COVID-19 or become severely ill. Alternatively, they discovered that those eating poorer quality diets are more at risk, especially if they live in a more socioeconomically deprived area. The findings are published in medRxiv online as a preprint. Key points from the study: Researchers analyzed data from nearly 600,000 ZOE COVID Study app contributors who completed a survey about the food they ate during Feb 2020 (pre-pandemic), making it the largest study in this space. People with the highest quality diet were around 10% less likely to develop COVID-19 than those with the lowest quality diet, and 40% less likely to become severely ill. This is the first longitudinal study of diet and COVID-19 and the first to show that a healthy diet cuts the chances of developing the disease in the first place. The scale of the study meant researchers were able to adjust for multiple confounding factors, which can be a challenge for studies of smaller sizes. The effect of diet on COVID-19 is independent of other known risk factors, including age, weight, race, ethnicity and underlying health conditions, but was amplified by social inequality. Measuring diet quality While it is already known that diet-related health conditions like diabetes, heart disease and obesity increase the chances of becoming seriously ill with COVID-19, it is not yet clear how the foods people eat affect their risk of catching the virus independently of these factors. To learn more about the interplay between food and health, the team analyzed data from 592,571 UK and US contributors who completed a survey about their eating habits within the ZOE COVID Study app. Based on analysis of symptoms or PCR test results reported in the app, 31,815 contributors (19%) ultimately caught COVID-19. Rather than looking at specific foods or nutrients, the survey was designed to look at broader dietary patterns which are reflective of how we actually eat. The survey produced a ‘diet quality score’ that reflected the overall merit of each person’s diet. Diets with high quality scores were found to contain plant-based foods such as fruits, vegetables, whole grains and nuts, as well as oily fish, healthier fats like olive oil, less processed foods and refined carbohydrates. High quality diet scores were also linked with a ‘healthier’ and a more diverse gut microbiome, which was also associated with a wide range of favorable health outcomes, including reduced inflammation and body fat and improved levels of blood lipids and glucose. For these aforementioned reasons, higher quality scoring diets were also referred to as ‘gut-friendly’ diets. A low diet quality score is associated with diets high in ultra processed foods and low amounts of plant-based foods, like fruit and vegetables. Connecting diet and COVID-19 risk The researchers found that people who ate the highest quality diet were around 10% less likely to develop COVID-19 than those with the least nutritious diet and 40% less likely to become severely ill if they developed COVID-19. Recent research on a smaller cross-sectional sample has shown that people who eat a plant-based or pescatarian** diet are less likely to become severely ill with COVID-19. However, this is the first study to show that a healthier diet actually reduces the chances of developing the disease in the first place. Importantly, the relationship between diet quality and COVID-19 risk still remained after accounting for all potential confounding factors. Factors included age, body mass index (BMI), ethnicity, smoking, physical activity and underlying health conditions. Mask-wearing habits and population density were also considered. Strikingly, the impact of diet was amplified by individual life situations, with people living in low-income neighborhoods and having the lowest quality diet being around 25% more at risk from COVID-19 than people in more affluent communities who were eating in the same way. Based on these results, the researchers estimate that nearly a quarter of COVID-19 cases could have been prevented if these differences in diet quality and socioeconomic status had not existed. This further highlights that improved access to nutritious, healthier food could be substantive for bettering public health, especially among the underprivileged members of the community. Professor Tim Spector, lead scientist at ZOE COVID Study and professor of genetic epidemiology at King’s College London, said: “These findings chime with recent results from our landmark PREDICT study, showing that people who eat higher quality diets (with low levels of ultra-processed foods) also have a healthier collection of microbes in their guts, which is linked to better health. You don’t have to go vegan, but getting more diverse plants on your plate is a great way to boost the health of your gut microbiome, improve your immunity and overall health, and potentially reduce your risk from COVID-19.” Dr Sarah Berry, study co-lead and associate professor in nutritional sciences at King’s College London, said: “For the first time we’ve been able to show that a healthier diet can cut the chances of catching COVID-19, especially for people living in the poorest areas. Access to healthier food is important to everyone in society, but our findings tell us that helping those living in more deprived areas to eat more healthily could have the biggest public health benefits.” Professor Andrew Chan MD, MPH, gastroenterologist and director of epidemiology at Massachusetts General Hospital, and professor at Harvard Medical School, said: “ Diet quality is an established risk factor for many conditions that are known to have an inflammatory basis. Our study demonstrates that this may also hold true for COVID-19, a virus which is known to provoke a severe inflammatory response. We also highlight how diet quality is also an important social determinant of health. COVID-19 has laid bare how such social determinants underlie the severe racial and socioeconomic disparities in COVID-19 risk that we and others have documented.” Jonathan Wolf, CEO of ZOE, added: “At ZOE we’re using the latest data science to unpick the complex connections between diet and health, bringing together our expertise in COVID-19 and nutrition to help improve health for all.” NOTES TO EDITORS For more information about the ZOE COVID Study app or to request an interview with Professor Tim Spector, please contact Eleanor Griffiths: +44 (0)7950 335916 eleanor@joinzoe.com For more information about ZOE or to request an interview with Jonathan Wolf, please contact; Fiana Tulip: fiana@joinzoe.com Preprint available here: Diet quality and risk and severity of COVID-19: a prospective cohort study. The research team includes scientists from: King’s College London; Massachusetts General Hospital, Harvard Medical School and the Harvard T.H. Chan School of Public Health, Boston, USA; The Broad Institute, Cambridge, USA; UTHealth, Texas, USA; Lund University, Sweden; ZOE Global Ltd. *A gut-friendly diet explained: A high quality diet contains more plant-based foods such as fruits, vegetables, whole grains and nuts as well as oily fish and healthier fats like olive oil and less processed foods and refined carbohydrates. This diet quality score is associated with a ‘healthier’ more diverse gut microbiome, which in turn is associated with a wide range of favorable health outcomes, including lower inflammation and body fat and improved blood lipids and glucose. **A pescatarian diet is predominantly vegetarian but includes fish and seafood. About ZOE ZOE is a healthcare science company helping people understand their body’s responses to food. By using machine learning combined with large scale human studies, ZOE is decoding the impact of nutrition on health. ZOE leads the PREDICT Studies and the ZOE COVID Study, which are the world’s largest community powered research programs of their kind in nutrition and COVID-19 respectively. Located in London and Boston, ZOE was founded by Professor Tim Spector of King’s College London, data science leader Jonathan Wolf and entrepreneur George Hadjigeorgiou. ZOE was named one of the Deloitte Fast 50 Rising Stars in 2019 for the company’s contribution to science enabled by technology and machine learning.For more information on ZOE’s mission and science, visit joinzoe.com About ZOE COVID Study The ZOE COVID Study is a not-for-profit initiative that was launched at the end of March 2020 to support vital COVID-19 research. The app was launched by health science company ZOE with scientific analysis provided by King’s College London. With 4 million contributors globally, the study is the world’s largest ongoing study of COVID-19 and is led by ZOE Co-Founder and King’s College London Professor, Tim Spector. The team has published over 20 research papers since March, most notably in Nature Medicine. To date the app is funded by the Department of Health and Social Care. The funding was awarded to enable the app to continue collecting data from its 4million+ users to help the UK government's response to COVID-19 and beyond. The app provides unique insight on asymptomatic and symptomatic information across the UK with 1.2 million logging on a weekly basis. For more information on The COVID Symptom Study app visit covid.joinzoe.com. Contact Details ZOE Fiana Tulip +1 817-691-3031 fiana@joinzoe.com Company Website https://www.joinzoe.com

July 13, 2021 09:13 AM Eastern Daylight Time

Image
Article thumbnail News Release

NextFerm Technologies obtains Regulatory Approval to market Astaferm® Astaxanthin Antioxidant in Canada

NextFerm Technologies Ltd.

NextFerm Technologies (TASE:NXFR), a food-tech company developing ProteVin™, a vegan, yeast-based, non-GMO protein alternative and other innovative yeast-based nutrients, today announced that Health Canada has granted a regulatory marketing approval for Astaferm®, its innovative fermented astaxanthin antioxidant in the form of Gummies. This is the only fermented astaxanthin with no odor and flavor. Along with the receipt of Astaferm®’s license approval (NPN - Natural Product Number), the company is preparing for the launch of several applications of Astaferm® in North America, including for Immunity support, which is a growing segment due to the Covid-19 pandemic. The Company has already supplied initial quantities of Astaferm® in Canada and is currently in dialogues with potential customers. Astaferm® has a US Self GRAS regulatory approval and was launched in the US at the end of 2020. The product is in early stages of sales, by well-known US dietary supplement brands, such as Carlson Labs and Purity Products. Since Astaferm® is flavorless and odorless, the Gummies application constitutes a significant differentiation from other astaxanthin products available on the market, produced from algae with fishy odor, and therefore applied mainly in soft-gels. NextFerm currently prepares to expand the marketing of Astaferm® for additional indications such as immune system support, as well as expanding into additional serving forms, such as water-dispersible powder for food and beverages, and fermented Astaferm® oil for soft-gels with competitive pricing. Boaz Noy, Chief Executive Officer of NextFerm, said, “The regulatory approval received for Astaferm® in Canada strengthens our presence in the North American dietary supplement market. This emphasizes Nextferm's ability to bring innovative nutritional ingredients from R&D to commercialization and sales. We have already started with an initial supply of the product to a customer in Canada and anticipate further launches in light of the differentiation with competing algae-based products that have fishy odor. This is thanks to a unique value proposition that combines a high astaxanthin concentration, without flavor and odor, which allows it to be integrated in delicious gummies and other food applications. At the same time, we are progressing according to our plan for the commercial launch of ProteVin ™, our vegan protein, in 2022.” About NextFerm Technologies NextFerm Technologies, traded on the Tel Aviv Stock Exchange (TASE:NXFR) is a food-tech company engaged in the research, development, manufacturing and marketing of innovative, functional and vegan yeast-derived, non-GMO protein alternatives for various applications in the food and food supplement markets and the growing market for animal-derived protein alternatives. NextFerm's flagship product is ProteVin™, a vegan, yeast-derived protein alternative with nutritional value that is similar to animal-derived protein and a neutral flavor, with no aftertastes that are typical of plant-based protein. ProteVin™ is designed for a variety of categories in the alternative protein market, which is estimated at $13 billion, with an annual growth rate of 10%, including milk and dairy substitutes, meat substitutes and additional categories such as infant nutrition, adult nutrition, and sports nutrition. NextFerm is gearing up for commercialization of the product in the US in 2022. Another product currently being sold is Astaferm®, an innovative astaxanthin-based antioxidant derived from yeast that has been sold in the US since the end of 2020 through well-established and leading brands in the food supplement market in the US. The company has additional products which have been licensed to Lallemand, a global giant focused on yeast. For more information, visit the NextFerm website at: www.nextferm.com Legal Notice Regarding Forward-Looking Statements This announcement also includes forecasts, projections, assessments, estimates and other information which refer to future events and matters, the realization of which is uncertain and not exclusively under the Company’s control (forward-looking information). The main facts and data used to support this information are facts and data regarding the current position of the Company and its businesses (including the scope of sales and levels of profitability, manpower, commercial engagements and more), facts and data regarding the current global position of the Company’s operating segments (including industry-specific financial developments, environmental regulatory developments, the competitive environment, technological developments, the reinsurance market and more), and macro-economic facts and data (including the economic situation both in Israel and around the world, yields in the capital markets, social and state developments and more), all as known by the Company when publishing this announcement. The forward-looking information included above in this announcement is significantly based upon, in addition to the existing information held by the Company, on the Company’s current assessments and expectations of future developments vis-a-vis each one of the aforementioned parameters, and the interconnectedness of each one of these developments. The Company has no certainty that its forecasts and assessments will indeed eventuate, and the Company’s operating results may be materially different than the results assessed or implicit based on that set forth above, inter alia, as a result of a change in any of the aforementioned factors. Contact Details NextFerm Technologies Ltd. Yossi Ohana - Chief Financial Officer +972 54-771-5893 yossio@nextferm.com Investor and Media Contact Meirav Gomeh-Bauer +972544764979 meirav@bauerg.com Company Website https://www.nextferm.com/

July 12, 2021 12:51 PM Eastern Daylight Time

Article thumbnail News Release

25-Year Independent Printing Business Custom Printing Converts to International Minute Press Franchise in Nampa, Idaho

Minuteman Press International Inc

Mike Cutler started selling print out of his garage in 1996. Over the next 25 years, Mike built a successful printing business that averaged over $1 million in gross sales over the past 5 years. Mike shares his experience in attempting to sell his independent printing company Custom Printing on his own for six to eight months and reveals how Minuteman Press International was able to step in to help him successfully sell the business. History of Custom Printing Mike says, “Custom Printing was a true family business I built from the ground up. I learned the printing trade through my father, who was a line and typesetter dating back to the 1950s. After starting the business in 1996, I quickly out-grew my garage and opened my first retail location in 1998. At the time, my specialties were thermography, offset printing, and stationery (envelopes and forms). By 2006, we out-grew the original location and expanded to a 6,000 sq. ft. facility. Between 2006 and 2014, I completed eight acquisitions to expand my business. The companies I acquired were in the areas of large format printing and signs, lithography, trophies, and reprographics.” Mike continues, “In 2015, we expanded even more, giving us 8,200 sq. ft. of space to work with. When the pandemic hit in 2020, we actually excelled and recorded our biggest sales year operating as an essential business. At the time of the sale, we had nine full-time employees and some part-time staff. Our 5-year average was $1.2 million in yearly sales.” Selling the Business By June 2020, Mike decided that it was time to sell Custom Printing. At first, he was asking different colleagues and people he knew. However, Mike quickly realized that this wasn’t going to be easy. He says, “I tried to sell the business that I worked so hard to build for six to eight months on my own. I was also preparing to let it go at a very undervalued price as I couldn’t find the right people to buy the business and I found many of them were time-wasters and tire-kickers. On top of that, when I consulted with a business broker, they were asking me for 10% off the top of the sale, and they also wanted a percentage of my lease agreement.” After experiencing these challenges on his own, Mike turned to Minuteman Press International to help sell his printing business. “One of the franchisees I knew locally in Idaho referred me to Chris Jutt, Minuteman Press International Regional Vice President. After our first phone call, I felt confident that Chris had the ability, drive and connections to make this dream a reality for me. Our meetings were always super easy going and comfortable. Chris took all the pressure off of me and said to focus on my successful business and he would do the rest. That is just what he did.” Before meeting with Minuteman Press International, Mike even went as far as to get a professional valuation of his printing business. He shares, “When I knew I was going to be selling, I made sure to get the shop ready. I made sure my financials were in proper order, I kept up with equipment maintenance and repairs, and I kept running and growing my business. Just to get a valuation of my business, I spent $3,000 to get it done professionally. Minuteman Press International did this for free and came up with the same number. That really impressed me and reassured me that the sale of Custom Printing was in capable hands.” “We set a price for my independent printing business that was significantly higher than I anticipated, and Chris Jutt recommended some terms. Within one week, I had several very interested parties. Chris found the perfect people to purchase my business – James and Sheryl Wisler – that will continue what I started some 25 years ago. Minuteman Press International knew that the most important things to me were my long-term employees, my clients, and the reputation I had worked so hard to build. Chris found buyers that valued the same things. He and the entire team at Minuteman Press International delivered on all of my expectations and exceeded in most of them. Looking back, if I knew this was going to be this easy, I would have contacted him years ago.” -Mike Cutler, independent print operator, Custom Printing (now International Minute Press, Nampa, Idaho ) Transition to New Owners After the sale of his business, Mike quickly realized how beneficial it was to have the team at Minuteman Press International assist with all aspects of the transition to the new owners. He shares, “At first, I was apprehensive about how the transition would go. I was immediately relieved when I saw how Minuteman Press International took the reins to teach and train James and Sheryl. We are only two and a half weeks into the transition phase, and already I feel like I am not needed as much as I thought I would be. My employees are in great hands, my clients are being taken care of, and James and Sheryl are doing a fantastic job.” He adds, “The entire team both here locally and at their corporate headquarters has been phenomenal. No matter who I’ve talked to or worked with during this entire process, everyone has been professional as well as instrumental in making this happen. It’s a win-win situation all around.” “The smooth transition has reassured me that it was the right move to sell my business with Minuteman Press International. They have the right plan, the right experience, and everyone has been incredible to the very last detail. In my acquisition experience, nothing has ever been as easy as this. I had everything to gain and nothing to lose, and there were absolutely no hiccups along the way. I would easily rate my experience as 10/10.” -Mike Cutler Advice to Other Sellers When asked what advice he would give to other print shop owners looking to sell, Mike answers, “Don’t even waste your time trying to do this yourself. When you try to sell on your own, there are so many bottleneck issues and you will likely undervalue your business. I couldn’t find the right buyers on my own and I had to spend too much time to meet with people repeatedly while still running my own business.” Mike concludes, “Minuteman Press International alleviated the bottlenecks and came forward with qualified buyers who were ready to write the check for the right price. I am 100% satisfied beyond my expectations. This was a total team effort by everyone, and they all came through for me.” Contact Minuteman Press International today for a free valuation at no obligation and learn more about how we can help you sell your printing business at no cost to you. Call us at 1-800-645-3006 or visit https://bit.ly/minutemanpressconversions Contact Details Minuteman Press International Chris Biscuiti +1 631-249-1370 cbiscuiti@mpihq.com Company Website https://minutemanpressfranchise.com

July 12, 2021 12:00 PM Eastern Daylight Time

Image
Article thumbnail News Release

New Website Created by Quidel Corporation Provides Consumers With Information and Easy-to-Understand Answers Regarding Lyme Disease

Quidel Corporation

Americans looking for information regarding Lyme disease, often referred to as the “epidemic within the pandemic,” now have a new and trusted resource in which to rely with the launch of LymeDiseaseAnswers.com. Created by Quidel Corporation, the website provides consumers with the peace of mind that comes with increased knowledge of the prevalence, causes, warning signs, symptoms and advances in the testing of Lyme disease, which afflicts nearly 480,000 people across the country each year. “Lyme disease can strike anyone of any age, especially those who spend time in wooded or grassy areas or who play sports on grass fields in high-risk areas of the country,” said Cheryl Miller, vice president of new market development for Quidel. “People are rightfully concerned about contracting Lyme disease and want to know how to avoid it, especially now with Americans spending more and more time outdoors as we emerge from the COVID-19 pandemic. We’ve created LymeDiseaseAnswers.com as a consumer-friendly and straight-talk place where people can easily find the information they are seeking.” The new website, created in tandem is Quidel’s strategic and creative partner breakwhitelight, contains answers to frequently asked questions, easy-to-understand infographics showing where Lyme disease is most prevalent and how it is contracted, the latest statistics and clinical research taking place regarding the disease, and links to additional resources on the subject. Also housed on the site is a series of recently produced “Quick Takes”—attention-grabbing educational videos that help consumers and health care professionals alike enhance their knowledge of Lyme disease by providing the information and up-to-the-minute data needed to confront this disease quickly and clearly. Quidel is the diagnostic health care manufacturer behind the industry’s most rapid and reliable in-office test for Lyme disease, the Sofia 2 Lyme FIA test. This test provides a patient as well as his or her physician with indicative results within minutes as opposed to days, which has historically been the norm. Performed in the privacy of a doctor’s office or local clinic, it is also the only test that can get results from a simple finger prick of blood. Given that the vast majority of patients tested are negative, not having to wait days for test results allows physicians and nurse practitioners to more rapidly treat those patients with positive results while more quickly pursuing other diagnosis and treatment for those who test negative. While just launching this month, LymeDiseaseAnswers.com has already been honored for excellence by the renowned MarCom Awards, an international creative competition that recognizes outstanding achievement by marketing and communications professionals, both corporate and agency. LymeDiseaseAnswers.com received MarCom’s highest award—its Platinum Award—while competing against more than 6,500 entries from the United States and several foreign countries. About Quidel Corporation Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic solutions at the point of care delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world. For more information about Quidel, visit quidel.com. Contact Details Jim Yeager +1 818-264-6812 jim@breakwhitelight.com Company Website http://Quidel.com

July 12, 2021 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Cyvatar Takes Home Top Prize in 2021 Fortress Awards

Cyvatar

Cyvatar today received more industry accolades as it was named a winner in network security by the Business Intelligence Group for its innovative Cybersecurity-as-a-Service (CSaaS) offering as part of the 2021 Fortress Cybersecurity Awards. The Fortress awards program identifies and rewards the world’s leading companies and products that are working to keep data and electronic assets safe among a growing threat from hackers. “2021 is rapidly becoming the toughest year for cybersecurity professionals and as our reliance on networks continues to accelerate, our identities and data have quickly become global currency, so security is more important than ever,” said Maria Jimenez, chief nominations officer at the Business Intelligence Group. “We are proud to recognize all of our winners and finalists who are on the frontlines of the effort to prepare, defend and respond to this growing threat.” Cyvatar’s proprietary ICARM method guarantees proper installation, configuration, assessment, remediation, and maintenance for every Cyvatar technology solution so that organizations actually achieve better protection and resilience from their investments And because Cyvatar’s method is continuous, it protects against attack vectors that haven’t even surfaced yet. “It’s continued validation of our unique CSaaS model that industry peers recognized Cyvatar again for exceptional leadership and innovation,” said Cyvatar Co-Founder and Chief Product and Strategy Officer Craig Goodwin. “As the first subscription-based CSaaS company to deliver effortless, affordable cybersecurity, we enable our members to protect confidential information with the people, processes, and technology essential to ensure they get value from their security tools, from conception and strategy to implementation and maintenance. No other provider delivers holistic security at price points that work for any size customer and guaranteed value that allows customers to cancel anytime.” Cyvatar CSaaS levels the playing field by democratizing cybersecurity and making the best protection accessible and affordable for every size organization, even if they have no cybersecurity expertise in-house. If your organization needs award-winning cybersecurity, Cyvatar can help. About Cyber Defense Magazine With over 5 Million monthly readers and growing, and thousands of pages of searchable online infosec content, Cyber Defense Magazine is the premier source of IT Security information for B2B and B2G with our sister magazine Cyber Security Magazine for B2C. We are managed and published by and for ethical, honest, passionate information security professionals. Our mission is to share cutting-edge knowledge, real-world stories and awards on the best ideas, products and services in the information technology industry. We deliver electronic magazines every month online for free, and special editions exclusively for the RSA Conferences. CDM is a proud member of the Cyber Defense Media Group. Learn more about us at https://www.cyberdefensemagazine.com and visit https://www.cyberdefensetv.com and https://www.cyberdefenseradio.com to see and hear some of the most informative interviews of many of these winning company executives. Join a webinar at https://www.cyberdefensewebinars.com and realize that infosec knowledge is power. About Cyvatar Cyvatar is committed to effortless cybersecurity for everyone. As the industry’s first subscription-based, cybersecurity-as-a-service (CSaaS) company, it’s our mission to transform the way the security industry builds, sells, and supports cyber solutions. We empower our members to achieve successful outcomes by providing expert advisors, proven technologies, and a strategic process roadmap to guarantee results that map to their business drivers. Our approach is rooted in proprietary ICARM (installation, configuration, assessment, remediation, maintenance) methodology that delivers smarter, measurable security solutions for superior compliance and cyber-attack protection faster and more efficiently, all at a fixed monthly price. And because we’re a subscription, members can cancel anytime. Cyvatar is headquartered in Irvine, California with locations around the world. Begin your journey to security confidence at CYVATAR.AI and follow us on LinkedIn and Twitter. Contact Details Cyvatar KC Higgins +1 303-434-8163 kc@cyvatar.ai Cyber Defense Magazine April Palanca +18338449468 Company Website https://cyvatar.ai/

July 07, 2021 11:51 AM Eastern Daylight Time

Article thumbnail News Release

Tapatío Hot Sauce Partners with comedian Gabriel “Fluffy” Iglesias to Celebrate 50th Anniversary

Tapatio Hot Sauce

Tapatío Hot Sauce, a national leader in the hot sauce industry, is celebrating 50 years since its creation in Southern California. And to commemorate this milestone, Tapatio has produced an exclusive 50th Anniversary memorabilia collection and all-new commemorative merchandise line. As part of the anniversary celebrations. Tapatío Hot Sauce has partnered with comedian and actor Gabriel " Fluffy" Iglesias to create a limited edition bottle, which features " Fluffy" and his beloved pet chihuahuas. The collaboration also includes a video series available on all social media platforms featuring " Fluffy" with local celebrity chefs including Chef Ludo Lefebvre from Petit Trois, Bricia Lopez from Guelaguetza, Chef Mario Christerna from Brooklyn Ave Pizza, and Chef Wes Avila of Angry Egret Dinette. “Like so many Californians, I grew up enjoying Tapatío with my family and friends, and have continued to do so for more than 30 years.” said " Fluffy". “And It’s a real honor and privilege to be featured on the front of the iconic bottle today; Tapatío is Mexican royalty – and I get to be King for a day!” Founder and CEO Jose-Luis Saavedra, Sr established the company’s humble beginnings in 1971. He had been laid off from his job and needed to provide for his family. At the time there were only three major hot sauce brands on the market, and Jose-Luis felt his own hot sauce tasted better. This inspired him to create Tapatío (the name given to people from Guadalajara, Mexico, his childrens’ birthplace). To make it happen, Jose-Luis leased a 750 square-foot building in Maywood, in Los Angeles County, and began with only the 5-ounce bottle size. Fourteen years later, Saavedra Sr realized he needed a bigger warehouse and moved Tapatío into a 8,500 square-foot warehouse less than a mile away. His three children, then out of college, joined him. His son, Luis Saavedra Jr, graduated medical school but gave up a career in medicine to help his father grow the family business. He is now Vice President of Tapatío and runs the company with his two sisters, Dolores Saavedra-McCoy, who completed law school and is now a Partner & Director of Merchandising, and Jacqueline Saavedra-Mora, who has a degree in Business Administration and is a Partner and Chief Financial Officer. Additionally, three members of the third generation of the Saavedra family also work at Tapatío. And it’s as a result of this continuity that Tapatío has remained true to its humble origins, producing the same high-quality, great-tasting product that can be found in households across the country and around the world. Today, Tapatío is housed in a custom-built, state-of-the-art, 30,000 square-foot facility in Vernon, CA. And Jose-Luis Saavedra Sr continues to work seven days a week, regularly visiting the warehouse. It’s thanks to his original vision that Tapatío is the #1 hot sauce on the West Coast, the third best-selling hot sauce in the United States, and is exported to more than 30 countries. “When Tapatio was founded more than five decades ago, we had no idea it would grow into the household name it has become today,” said Luis Saavedra Jr. “We’re still dedicated to providing quality products and service to our customers, and we’re always tailoring our approach to meet our customers’ needs, both at home and around the world. We’re excited to celebrate 50 years of business with Fluffy and look forward to another 50 years to come!” Link to Tapatio webstore: Shop — Tapatio Hot Sauce View the Tapatio 50th Anniversary video series here: Tapatio YouTube Channel Tapatio Foods, LLC was founded in 1971 from humble beginnings. Fifty years later, Tapatio is still a family-run business and has grown to become a staple, not only in Hispanic households but in most American households. It is the #1 hot sauce in the west, the #3 hot sauce in the USA, and is now exporting globally! Tapatio is a sauce that can be used with everything and is available in many different sizes. For more information, please visit tapatiohotsauce.com Contact Details The ID Agency Victor Carrillo +1 310-963-3400 victor@theidagency.com Company Website https://www.tapatiohotsauce.com/

July 07, 2021 07:00 AM Pacific Daylight Time

Video Image
Article thumbnail News Release

Introducing YuCALM®, Natural Calming Chews for Stressed or Anxious Dogs

Lintbells

Lintbells, manufacturer of leading hip and joint supplement for dogs, YuMOVE®, is excited to announce its latest in natural* health products with the launch of YuCALM®. Available on Chewy.com, YuCALM® ONE-A-DAY chews for dogs of all sizes, contains science-backed ingredients to help dogs cope with stress and anxiety. “Many dogs feel anxious on a daily basis or are fearful toward specific triggers such as thunderstorms, fireworks, or new situations like owners returning back to the office,” said John Howie, CEO and co-founder of Lintbells. “By supporting natural calming pathways in the brain, YuCALM® ONE-A-DAY is a safe and effective way to reduce stress and support calm behavior.” Easy to use format. YuCALM® ONE-A-DAY comes in a handy tasty bite dogs love, that makes feeding a breeze. Lemon balm helps dogs feel more relaxed, soothing stress and encouraging calming behavior. L-Theanine offers natural calming properties that support the production of calming compounds such as serotonin. B Vitamins support healthy brain function, reducing excitability and improving concentration. Proprietary blend of natural fish protein hydrolysates helps calming signals locate the right spot in the brain. “We recommend pets be on a daily regimen of YuCALM® approximately four to six weeks in advance of any expected triggering events such as holiday celebrations, major traveling, or family members heading back to school,” adds Howie. “We’re thrilled to offer pet owners a safe and effective solution for their anxious four-legged friends.” Product samples, images, and veterinary and expert interviews available upon request. *Over 90% of ingredients natural. For the full definition please visit yumove.com/natural. About Lintbells Lintbells, the UK's #1 Vet Recommended Dog Joint Supplement company, currently helps more than 1 million dogs across Europe and the United States. In March 2019, Lintbells officially entered the US Market with the introduction of their most popular product abroad, YuMOVE Soft Chews. This joint supplement promotes joint and cartilage health in dogs of all breeds and sizes. Made from all-natural, human-grade, non-GMO ingredients, the secret to YuMOVE Soft Chews' success comes from Lintbells own ActivEase® Green Lipped Mussel (or GLM). GLM, a superfood derived from the purest sources in New Zealand, is an essential ingredient with extraordinary properties that improves joint function, mobility, and reduces discomfort in our dogs. This unique ingredient, rich with more Omega 3s than any other GLM, is naturally anti-inflammatory, meaning our dog's stiff joints are eased naturally. To learn more, visit www.yumove.com Contact Details The Impetus Agency Jamie Baxter +1 775-322-4022 jamie@theimpetusagency.com Company Website https://yumove.com/

July 07, 2021 06:12 AM Pacific Daylight Time

Article thumbnail News Release

What You Need to Know About Heart Disease

YourUpdateTV

As the world looks with hope to the light at the end of the COVID-19 tunnel, there lies another ongoing health crisis that, according to the American Heart Association (AHA), kills more Americans than anything else: heart disease. Recently, leading cardiologist and Director of Cardiology at State of the Art Cardiology, Dr. John Osborne, teamed with his patient Mike Hodge on a nationwide satellite media tour to discuss managing cardiovascular risk. A video accompanying the announcement can be found here: https://youtu.be/XKKKCVCofew In the last year, heart disease claimed more than 690,000 lives in the U.S., which is staggeringly more than the reported 345,000 lives lost to COVID-19, according to data from the Centers for Disease Control. While the prevalence of the disease – and incredible amounts of research – would lead many to think the risks and standard practices would be widely known, the overwhelming amount of information and data can actually make it harder to assess risk and treatment options, which can be confusing for physicians and patients alike. For example, many people are unaware that after a failed outcomes study, the FDA revoked the approval of a class of drugs called fenofibrates — such as TriCor ® (fenofibrate) and Trilipix ® (fenofibric acid) — concluding that fenofibrates should not be used in combination with statins for CV risk reduction because the risks outweigh the benefits. As a result, millions of patients at risk of heart attack or stroke may be unknowingly receiving medications that have not been shown to reduce cardiovascular (CV) risk on top of statins. According to Dr. Osborne, patients who are taking a fenofibrate, in addition to a statin, are taking a drug that has not shown CV benefit and instead just exposes them to the potential risks of these medicines which outweigh the benefits. For more information, visit itscleartomenow.com About Dr. John Osborne: Dr. Osborne has been recognized as a Fellow of the American College of Cardiology and a Fellow of the National Lipid Association. His clinical interests include preventive cardiology, metabolic syndrome and diabetes, hypertension, congestive heart failure, cholesterol disorders, coagulation disorders, and cardiovascular genetics. He is the founder and director of State of the Heart Cardiology in Dallas, Texas and is currently the National Director of Cardiology, Preventive Cardiology, and Lipidology for the Low T Centers and HerKare. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

July 06, 2021 02:00 PM Eastern Daylight Time

Video
Article thumbnail News Release

happiTV chooses CIPIO’s Next-Gen Subscriber Experience Platform to Meet Demand of Subscription Growth

CIPIO.ai

CIPIO, an AI company that is Humanizing Subscriptions TM, today announced happiTV adopts CIPIO’s Next-Gen Subscriber Experience (SX) Platform TM to fuel growth. The LGBTQ+ community continues to play a pivotal role in shaping modern society. As a leading voice of the community, happiTV curates and delivers cutting-edge and award-winning content across major streaming devices and services including Roku, Amazon Fire, Android TV, and iOS. In anticipation of exponential growth of viewership and engagement, happiTV looks to CIPIO to lead efforts to drive a deeper relationship between Subscriptions and Subscribers. “Based on the overwhelming support of Pride Month, we have experienced a massive shift in thinking and mindset around acceptance of LGBTQ+ specific content programming. Our growth is directly tied to this shifting mindset and we need to effectively scale with the demand,” said Daniel Bort, CEO of happiTV. “Through their cutting edge AI platform and to meet the demand for our content, CIPIO provides us the ability to provide world-class user experiences for our subscribers as if we were one of the media giants of the world. As a result of the collaboration, happiTV is equipped and prepared for exponential subscriber and revenue growth.” By Humanizing Subscriptions TM, CIPIO empowers modern digital businesses to significantly enhance subscriber experiences throughout the subscriber’s journey from the trial to paid to proactively retaining subscribers and optimizing content acquisition costs. “CIPIO is proud to support happiTV’ s mission to impact society through groundbreaking content and programming for the LGBTQ+ community. This relationship embodies our mission around Humanizing Subscriptions TM,” said Sundeep Sanghavi, CEO of CIPIO. “Our team is obsessed with supporting content businesses like happiTV and their ability to thrive in an ever-changing digital world. Our primary objective is to create a lifelong connection between happiTV subscribers and their subscriptions which ultimately will exceed business objectives and fuel growth.” Digital businesses continue to proliferate society globally. As content subscriptions grow, businesses like happiTV are faced with common challenges: churn, conversion from free to paid and optimizing content acquisition costs. Through CIPIO’s Subscriber Experience Platform TM, digital organizations can address these challenges head-on to keep pace with dynamic market pressure. CIPIO is rapidly gaining momentum in the media and entertainment space and is leveling the playing field by providing the enhanced AI capabilities with augmented data to any and all size media and entertainment organizations. About CIPIO CIPIO Inc. provides the leading patent-pending AI platform that Humanizes Subscriptions TM for digital organizations. By bringing together human, machine, and domain data, CIPIO arms organizations with capabilities to sense, learn, predict and recommend digital experiences to strengthen the subscriber and subscription relationship. CIPIO impacts both the top and bottom-line financials for some of the world’s leading brands such as happiTV, Zype, InteliVideo, and Jonas Fitness. Learn more about CIPIO here. About happiTV happiTV is a new entertainment app dedicated to streaming content of interest to the LGBTQ+ community. Delivering feature films, TV series, non-fiction, or short-form videos, happiTV serves as an anchor for positive role models and powerful messages for the queer population. Unlike any other, happiTV is a place where the community can find powerful entertainment and resources that will better their lives. We are a 100% minority-owned and operated enterprise (LGBTQ+ and Latino) in the United States of America. Please patronize our sponsors and enjoy the work of our partners and creatives. Together, we can bring smiles and big grins around the world. That's what we are all about. We are happiTV. Contact Details CIPIO Media Relations +1 315-398-9541 pr@cipio.ai Company Website https://cipio.ai/

July 06, 2021 08:00 AM Pacific Daylight Time

Image
1 ... 352353354355356 ... 400